Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000020

President & CEO acquired 103,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hirsch Andrew · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-14 Grant or award : show line 1 in the form +103,400 217,301 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-14 Grant or award : show line 2 in the form Stock Option (Right to Buy) +465,500 465,500 D
Loading xslF345X05/wk-form4_1708034921.xml…